DFX Intelligence

Data Factory

VentureFirmmulti stage vc · probableregistered_investment_adviser

Foresite Capital

Venture Capital

Larkspur, CA

We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:84553948-78c0-49db-835a-955d72cf7860

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 5:39 PM UTC and rebuilt at most every 15 minutes.

Relationships: 222
Dated events: 40
On other graphs: 2
Observed: Sep 12, 2026 to Sep 17, 2026
76 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Foresite Capital

Private equity manager · shared crd

RIA / Wealth Managementidentity

FORESITE CAPITAL

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 24
Vintages: 2013 to 2022
Regulatory AUM: $3.2B
Funds with fundraising evidence: 0derived
Investments: 153
Portfolio companies: 152
Investments, 12m: 153
Partner-attributed: 1
People: 44
Investment professionals: 20derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: ai,healthcare,biotechas stated by the firm
Stated stages: multi_stage
Latest Form D: Jun 23, 2023
Latest ADV filing: Jul 30, 2026
Website: foresitecapital.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
Foresite Capital Fund VI LP	2022	Active deployment	$551M	$723M
Foresite Capital Vi-A, LLC	2022	Active deployment	$0	$20.1M
Foresite Labs Fund I, L.P.	2021	Mature	$0	$154M
Foresite Capital Opportunity Fund V, L.P.	2019	Mature	$186M	$233M
Foresite Capital Fund V, L.P.	2019	Mature	$743M	$909M
Foresite Capital Fund IV, LP	2018	Harvest	$0	$1.2B
Foresite Capital V-D, LLC	2017	Wound down	n/a	$51.7M
Foresite Capital V-B, LLC	2016	Wound down	n/a	$21.3M
Foresite Capital V-C, LLC	2016	Wound down	n/a	$4.3M
Foresite Capital Fund III, LP	2016	Harvest	$0	$175M
Foresite Capital Iv-C, LLC	2014	Wound down	n/a	$4.0M
Foresite Capital V-A, LLC	2014	Wound down	n/a	$41.1M
Foresite Capital Iv-B, LLC	2014	Wound down	n/a	$18.8M
Foresite Capital Ii-A Management, LLC	2014	Wound down	n/a	$8.9M
Foresite Capital Ii-Aa, LLC	2013	Wound down	n/a	$0
Foresite Capital Fund I, LP	2013	Harvest	$0	$17.7M
Foresite Capital Fund II, LP	2013	Harvest	$279M	$43.1M
Foresite Capital Iv-A, LLC	2013	Harvest	n/a	$0
Foresite Capital I-A, LLC	n/a	Wound down	n/a	$2.1M
Foresite Capital Ii-A, LLC	n/a	Wound down	n/a	$0
Foresite Capital Iii-A, LLC	n/a	Wound down	n/a	$7.5M
Foresite Capital I-Ai, LLC	n/a	Wound down	n/a	$1.0M
Foresite Capital I-Aa, LLC	n/a	Wound down	n/a	$1.4M
Foresite Capital I-Aaa, LP	n/a	Wound down	n/a	$29.2M

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Healthcare Tech & Services	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
10x Genomics (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
89 Bio, Inc. (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Abdera Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Acceleron Pharma (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aclaris Therapeutics, Inc. (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Adaptimmune Therapeutics PLC (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Biopharmaceutical	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Beam Therapeutics Inc. (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Khartis Therapeutics, Inc.	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Kinnate Biopharma (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
MyOme, Inc.	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Mythic Therapeutics, Inc.	Ma	n/a	n/a	n/a	Unknown	Sep 16, 2026
Nested Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
NeuroDerm (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
NGM Biopharmaceuticals (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Peloton Therapeutics, Inc. (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Pharvaris	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
PHAXIAM Therapeutics S.A. (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Pinnacle Medicines, Inc.	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Pleno	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Quantum-Si (Alumni)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Quince Therapeutics, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 16, 2026
Alumni	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Foresite Capital	Arch Venture Partners	5	5	Sep 16, 2026	Strong
Foresite Capital	HOF Capital	2	2	Sep 16, 2026	Recurring
Foresite Capital	Decheng Capital LLC	2	2	Sep 16, 2026	Recurring
Foresite Capital	Fusion Fund Silicon Valley LLC	1	1	Sep 16, 2026	One time
Foresite Capital	Alkeon Capital Management, LLC	1	1	Sep 16, 2026	One time
Foresite Capital	Ansa Capital Management, LLC	1	1	Sep 16, 2026	One time
Foresite Capital	Wellington Management	1	1	Sep 16, 2026	One time
Solari Capital Management LLC	Foresite Capital	1	1	Sep 16, 2026	One time
Foresite Capital	Logos Capital	1	1	Mar 26, 2026	One time
Westlake Biopartners, LLC	Foresite Capital	1	1	Sep 16, 2026	One time
Lifeforce Capital Management, LLC	Foresite Capital	1	1	Sep 16, 2026	One time
Sempervirens Ventures LLC	Foresite Capital	1	1	Sep 16, 2026	One time
Quan Capital	Foresite Capital	1	1	Mar 26, 2026	One time
K50 Ventures	Foresite Capital	1	1	Sep 16, 2026	One time
Foresite Capital	HanKang Capital	1	1	Mar 26, 2026	One time

Relationships

showing 80 of 222

Invested in (80)

→ Edgewise Therapeutics (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Generation Bio (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Crossover Health, Inc. (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Dyax Corp (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Epizyme, Inc. (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ GalileoCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ CerevanceCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Crinetics Pharmaceuticals, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Denali Therapeutics Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ DNAnexus, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Eikon Therapeutics, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Engrail TherapeuticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Fabric Genomics, Inc. (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Fulcrum Therapeutics (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Candid Therapeutics (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Centessa Pharmaceuticals (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Color HealthCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Corvus PharmaceuticalsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Cullinan Therapeutics (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Delfi DiagnosticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Detect, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Disc MedicineCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Bit Bio LimitedCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Eidos Therapeutics, Inc. (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Element BiosciencesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ enGene Holdings Inc. (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Everly HealthCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ EvonetixCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ FibroGen (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Foresight Diagnostics (Alumni)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
and 50 more

Dated events

37 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Aug 1, 2017
Person joined
Amelia Buckley Stoj joined Schedule A of Foresite Capital as Chief Compliance Officer And Director Of Legal And Investor Relations
Form ADVobserved 8 days ago
Occurred
Jan 1, 2013
Person joined
Dennis Drew Ryan joined Schedule A of Foresite Capital as Chief Financial Officer
Form ADVobserved 8 days ago
Occurred
Mar 28, 2012
Adviser's first ADV filing
Foresite Capital first filed Form ADV (ERA)
Form ADVobserved 8 days ago

Show 37 bookkeeping events

First seen by DFX
Sep 17, 2026
date not stated
Life Sciences no longer listed on Foresite Capital's portfolio page
Occurred
Sep 28, 2022
Foresite Capital Fund VI LP first reported on Form ADV by Foresite Capital (Venture Capital Fund)
Occurred
Feb 16, 2022
Foresite Capital Vi-A, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund)
Occurred
Aug 23, 2021
Foresite Labs Fund I, L.P. first reported on Form ADV by Foresite Capital (Venture Capital Fund)
Occurred
Mar 15, 2021
Foresite Capital I-Ai, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital V-B, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital I-A, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital V-C, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital V-D, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital I-Aa, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 15, 2021
Foresite Capital V-A, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Aug 25, 2020
Foresite Capital Fund V, L.P. first reported on Form ADV by Foresite Capital (Hedge Fund)
Occurred
Aug 25, 2020
Foresite Capital Opportunity Fund V, L.P. first reported on Form ADV by Foresite Capital (Hedge Fund)
Occurred
Mar 29, 2018
Foresite Capital Iii-A, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Jan 31, 2018
Foresite Capital Fund IV, LP first reported on Form ADV by Foresite Capital (Hedge Fund)
Occurred
Mar 24, 2017
Foresite Capital V-D, LLC first reported on Form ADV by Foresite Capital (Private Equity Fund), GAV $77,304,131
Occurred
Mar 29, 2016
Foresite Capital Fund III, LP first reported on Form ADV by Foresite Capital (Private Equity Fund), GAV $460,250,829
Occurred
Mar 29, 2016
Foresite Capital V-C, LLC first reported on Form ADV by Foresite Capital (Private Equity Fund), GAV $6,321,249
Occurred
Mar 29, 2016
Foresite Capital V-B, LLC first reported on Form ADV by Foresite Capital (Private Equity Fund), GAV $31,016,300
Occurred
Mar 29, 2016
Foresite Capital I-Aaa, LP no longer reported on Form ADV by Foresite Capital
Occurred
Mar 29, 2016
Foresite Capital Iv-B, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 30, 2015
Foresite Capital Ii-Aa, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 30, 2015
Foresite Capital Ii-A Management, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 30, 2015
Foresite Capital Iv-C, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Mar 30, 2015
Foresite Capital Ii-A, LLC no longer reported on Form ADV by Foresite Capital
Occurred
Jun 25, 2014
Foresite Capital V-A, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $32,825,283
Occurred
Mar 28, 2014
Foresite Capital Iv-B, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $14,168,311
Occurred
Mar 28, 2014
Foresite Capital Iv-C, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $2,463,840
Occurred
Mar 28, 2014
Foresite Capital Ii-A Management, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $3,727,080
Occurred
Mar 28, 2014
Foresite Capital Fund II, LP first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $149,505,208
Occurred
Mar 28, 2013
Foresite Capital Iv-A, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund)
Occurred
Mar 28, 2013
Foresite Capital Fund I, LP first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $57,156,795
Occurred
Mar 28, 2013
Foresite Capital Ii-Aa, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $1,904,624
Occurred
Mar 28, 2012
Foresite Capital I-Ai, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $2,426,000
Occurred
Mar 28, 2012
Foresite Capital I-Aaa, LP first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $4,407,110
Occurred
Mar 28, 2012
Foresite Capital Iii-A, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $10,878,000
Occurred
Mar 28, 2012
Foresite Capital I-Aa, LLC first reported on Form ADV by Foresite Capital (Venture Capital Fund), GAV $3,558,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 2 business phones (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:84553948-78c0-49db-835a-955d72cf7860
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 3 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Foresite Capital

Venture Capital

Larkspur, CA

We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:84553948-78c0-49db-835a-955d72cf7860

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 5:39 PM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Foresite Capital Fund VI LP

2022

Active deployment

$551M

$723M

Foresite Capital Vi-A, LLC

2022

Active deployment

$20.1M

Foresite Labs Fund I, L.P.

2021

Mature

$154M

Foresite Capital Opportunity Fund V, L.P.

2019

Mature

$186M

$233M

Foresite Capital Fund V, L.P.

2019

Mature

$743M

$909M

Foresite Capital Fund IV, LP

2018

Harvest

$1.2B

Foresite Capital V-D, LLC

2017

Wound down

n/a

$51.7M

Foresite Capital V-B, LLC

2016

Wound down

n/a

$21.3M

Foresite Capital V-C, LLC

2016

Wound down

n/a

$4.3M

Foresite Capital Fund III, LP

2016

Harvest

$175M

Foresite Capital Iv-C, LLC

2014

Wound down

n/a

$4.0M

Foresite Capital V-A, LLC

2014

Wound down

n/a

$41.1M

Foresite Capital Iv-B, LLC

2014

Wound down

n/a

$18.8M

Foresite Capital Ii-A Management, LLC

2014

Wound down

n/a

$8.9M

Foresite Capital Ii-Aa, LLC

2013

Wound down

n/a

Foresite Capital Fund I, LP

2013

Harvest

$17.7M

Foresite Capital Fund II, LP

2013

Harvest

$279M

$43.1M

Foresite Capital Iv-A, LLC

2013

Harvest

n/a

Foresite Capital I-A, LLC

n/a

Wound down

n/a

$2.1M

Foresite Capital Ii-A, LLC

n/a

Wound down

n/a

Foresite Capital Iii-A, LLC

n/a

Wound down

n/a

$7.5M

Foresite Capital I-Ai, LLC

n/a

Wound down

n/a

$1.0M

Foresite Capital I-Aa, LLC

n/a

Wound down

n/a

$1.4M

Foresite Capital I-Aaa, LP

n/a

Wound down

n/a

$29.2M

Company

State

Stage

Round size

Partner

Attribution

Observed

Healthcare Tech & Services

n/a

Unknown

Sep 16, 2026

Therapeutics

n/a

Unknown

Sep 16, 2026

10x Genomics (Alumni)

n/a

Unknown

Sep 16, 2026

89 Bio, Inc. (Alumni)

n/a

Unknown

Sep 16, 2026

Abdera Therapeutics

n/a

Unknown

Sep 16, 2026

Acceleron Pharma (Alumni)

n/a

Unknown

Sep 16, 2026

Aclaris Therapeutics, Inc. (Alumni)

n/a

Unknown

Sep 16, 2026

Adaptimmune Therapeutics PLC (Alumni)

n/a

Unknown

Sep 16, 2026

Biopharmaceutical

n/a

Unknown

Sep 16, 2026

Beam Therapeutics Inc. (Alumni)

n/a

Unknown

Sep 16, 2026

Khartis Therapeutics, Inc.

n/a

Unknown

Sep 16, 2026

Kinnate Biopharma (Alumni)

n/a

Unknown

Sep 16, 2026

MyOme, Inc.

n/a

Unknown

Sep 16, 2026

Mythic Therapeutics, Inc.

n/a

Unknown

Sep 16, 2026

Nested Therapeutics

n/a

Unknown

Sep 16, 2026

NeuroDerm (Alumni)

n/a

Unknown

Sep 16, 2026

NGM Biopharmaceuticals (Alumni)

n/a

Unknown

Sep 16, 2026

Peloton Therapeutics, Inc. (Alumni)

n/a

Unknown

Sep 16, 2026

Pharvaris

n/a

Unknown

Sep 16, 2026

PHAXIAM Therapeutics S.A. (Alumni)

n/a

Unknown

Sep 16, 2026

Pinnacle Medicines, Inc.

n/a

Unknown

Sep 16, 2026

Pleno

n/a

Unknown

Sep 16, 2026

Quantum-Si (Alumni)

n/a

Unknown

Sep 16, 2026

Quince Therapeutics, Inc.

n/a

Unknown

Sep 16, 2026

Alumni

n/a

Unknown

Sep 16, 2026

Investor

Co-investor

Shared deals

Shared companies

Last observed

Strength

Foresite Capital

Arch Venture Partners

Sep 16, 2026

Strong

Foresite Capital

HOF Capital

Sep 16, 2026

Recurring

Foresite Capital

Decheng Capital LLC

Sep 16, 2026

Recurring

Foresite Capital

Fusion Fund Silicon Valley LLC

Sep 16, 2026

One time

Foresite Capital

Alkeon Capital Management, LLC

Sep 16, 2026

One time

Foresite Capital

Ansa Capital Management, LLC

Sep 16, 2026

One time

Foresite Capital

Wellington Management

Sep 16, 2026

One time

Solari Capital Management LLC

Foresite Capital

Sep 16, 2026

One time

Foresite Capital

Logos Capital

Mar 26, 2026

One time

Westlake Biopartners, LLC

Foresite Capital

Sep 16, 2026

One time

Lifeforce Capital Management, LLC

Foresite Capital

Sep 16, 2026

One time

Sempervirens Ventures LLC

Foresite Capital

Sep 16, 2026

One time

Quan Capital

Foresite Capital

Mar 26, 2026

One time

K50 Ventures

Foresite Capital

Sep 16, 2026

One time

Foresite Capital

HanKang Capital

Mar 26, 2026

One time